Breaking News Instant updates and real-time market news.

2021-01-27 14:09:23 AAPL Apple $143.30 / +0.13 (+0.09%) 14:09 01/27/21 01/27 14:09 01/27/21 14:09	Apple to accelerate production shift outside China, Nikkei Asia says Apple is ramping up output of iPhones, iPads, Macs, and other products outside of China in a sign that the company is continuing to accelerate its production diversification despite hopes that U.S.-China tensions will abate under new U.S. President Joe Biden, Nikkei Asia's Lauly Li and Cheng Ting-Fang report. The company intends to bolster its output shift to India and Vietnam, the authors note. Reference Link	27 Jan 23 Feb
AAPL Apple $143.30 / +0.13 (+0.09%) 01/26/21 Credit Suisse Credit Suisse could see software, battery as key underpinnings of Apple car 01/25/21 Morgan Stanley Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value 01/25/21 Evercore ISI Evercore ISI raises Apple price target to $160, sees higher odds of car product 01/25/21 Raymond James Apple price target raised to $150 from $140 at Raymond James

2021-01-27 14:09:23

AAPL

Apple

$143.30 / +0.13 (+0.09%)

14:09

01/27/21

01/27

14:09

01/27/21

14:09

Apple to accelerate production shift outside China, Nikkei Asia says

Apple is ramping up output of iPhones, iPads, Macs, and other products outside of China in a sign that the company is continuing to accelerate its production diversification despite hopes that U.S.-China tensions will abate under new U.S. President Joe Biden, Nikkei Asia's Lauly Li and Cheng Ting-Fang report. The company intends to bolster its output shift to India and Vietnam, the authors note. Reference Link

27
Jan
23
Feb

AAPL Apple

$143.30 / +0.13 (+0.09%)

01/26/21 Credit Suisse: Credit Suisse could see software, battery as key underpinnings of Apple car

01/25/21 Morgan Stanley: Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value

01/25/21 Evercore ISI: Evercore ISI raises Apple price target to $160, sees higher odds of car product

01/25/21 Raymond James: Apple price target raised to $150 from $140 at Raymond James

TODAY'S FREE FLY STORIES

Earnings	Autolus Therapeutics reports 2020 EPS ($2.76), consensus ($2.67) » 07:04 03/04/21 03/04 07:04 03/04/21 07:04 AUTL Autolus Therapeutics $6.44 / -0.35 (-5.15%) Reports Q4 revenue $1.7M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events AUTL Autolus Therapeutics $6.44 / -0.35 (-5.15%) 01/06/21 Autolus Therapeutics to reduce headcount by 20%, focus on AUTO1 12/07/20 Autolus Therapeutics: AUTO3 continues to show differentiated product profile 12/06/20 Autolus Therapeutics presents AUTO1 data from ALLCAR Phase 1 study in ALL 11/30/20 Autolus Therapeutics announces publication of AUTO6 Phase 1 data AUTL Autolus Therapeutics $6.44 / -0.35 (-5.15%) 01/29/21 JPMorgan Autolus Therapeutics downgraded to Neutral with $9 target at JPMorgan 01/29/21 JPMorgan Autolus Therapeutics downgraded to Neutral from Overweight at JPMorgan 01/07/21 Truist Autolus Therapeutics price target lowered to $15 from $30 at Truist 01/07/21 Mizuho Autolus Therapeutics price target lowered to $18 from $24 at Mizuho AUTL Autolus Therapeutics $6.44 / -0.35 (-5.15%) 11/05/20 Autolus Therapeutics reports Q3 EPS (72c), consensus (71c) 10 Feb 08:30 Today Autolus Therapeutics - AUTL
Recommendations	Ituran price target raised to $26 from $23 at Barclays » 07:04 03/04/21 03/04 07:04 03/04/21 07:04 ITRN Ituran $21.97 / +0.16 (+0.73%) Barclays analyst Tavy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research ITRN Ituran $21.97 / +0.16 (+0.73%) 03/03/21 Ituran to distribute 48c per share cash dividend ITRN Ituran $21.97 / +0.16 (+0.73%) 07/21/20 Jefferies Ituran downgraded to Hold on South America exposure at Jefferies 07/21/20 Jefferies Ituran downgraded to Hold from Buy at Jefferies
Earnings	Purple Innovation sees FY21 revenue $840M-$880M, consensus » 07:03 03/04/21 03/04 07:03 03/04/21 07:03 PRPL Purple Innovation $36.25 / -1.64 (-4.33%) Sees FY21 adjusted EBITDA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options PRPL Purple Innovation $36.25 / -1.64 (-4.33%) 10/19/20 Purple Innovation signs exclusive partnership with Sleep Country Canada PRPL Purple Innovation $36.25 / -1.64 (-4.33%) 01/12/21 B. Riley Securities Purple Innovation price target raised to $41 from $20 at B. Riley Securities 01/12/21 Wedbush Purple Innovation price target raised to $38 from $32 at Wedbush 12/16/20 Truist Purple Innovation initiated with a Buy at Truist 12/16/20 Evercore ISI Purple Innovation initiated with an Outperform at Evercore ISI PRPL Purple Innovation $36.25 / -1.64 (-4.33%) 07:02 Today Purple Innovation reports Q4 adjusted EPS 7c, consensus 11c 11/11/20 Notable companies reporting after market close 11/10/20 Purple Innovation reports Q3 adjusted EPS 27c, consensus 24c 10 Sep 15 May PRPL Purple Innovation $36.25 / -1.64 (-4.33%) 11/10/20 Fly Intel: After-Hours Movers 09/10/20 Fly Intel: Pre-market Movers 09/09/20 Fly Intel: After-Hours Movers 08:30 Today Purple Innovation - PRPL PRPL Purple Innovation $36.25 / -1.64 (-4.33%) 12/24/20 Purple Innovation call volume above normal and directionally bullish 12/07/20 Unusual call flow in option market yesterday 12/04/20 Unusual call volume in Purple Innovation as shares traded up 4% 12/01/20 Largest borrow rate increases among liquid names
Earnings	Ciena reports Q1 EPS 52c, consensus 45c » 07:03 03/04/21 03/04 07:03 03/04/21 07:03 CIEN Ciena $50.58 / -0.97 (-1.88%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CIEN Ciena $50.58 / -0.97 (-1.88%) 01/13/21 Consolidated Communications partners with Ciena to upgrade wireline network 12/10/20 Ciena sees FY21 annual revenue growth 0%-3%, sees stronger than typical 2H21 12/10/20 Ciena expects OpEx below revenue growth for next 3 years 12/10/20 Ciena: Not in a position to provide specific 3-year financial targets CIEN Ciena $50.58 / -0.97 (-1.88%) 02/25/21 Citi Ciena price target raised to $65 from $55 at Citi 01/21/21 Fly Intel: Top five analyst upgrades 01/21/21 BofA Ciena upgraded to Buy from Neutral at BofA 01/21/21 BofA Ciena upgraded to Buy from Neutral at BofA CIEN Ciena $50.58 / -0.97 (-1.88%) 03/03/21 Notable companies reporting before tomorrow's open 03/03/21 Notable companies reporting before tomorrow's open 12/10/20 Ciena sees FY21 revenue growth 0%-3%, consensus $3.54B 12/10/20 Ciena sees Q1 revenue $735M-$765M, consensus $759.07M CIEN Ciena $50.58 / -0.97 (-1.88%) 12/10/20 Fly Intel: Pre-market Movers 08:30 Today Ciena - CIEN 04/01/21 Ciena Corporation CIEN Ciena $50.58 / -0.97 (-1.88%) 11/12/20 Ciena put volume heavy and directionally bearish
Upgrade	Correction: U.S. Xpress Enterprises upgraded to Buy from Underperform at BofA » 07:02 03/04/21 03/04 07:02 03/04/21 07:02 USX U.S. Xpress Enterprises $10.32 / +0.47 (+4.77%) BofA analyst Ken Hoexter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events USX U.S. Xpress Enterprises $10.32 / +0.47 (+4.77%) 01/22/21 U.S. Xpress Enterprises falls -13.8% 01/22/21 U.S. Xpress Enterprises falls -10.9% 01/22/21 U.S. Xpress Enterprises falls -11.1% 10/23/20 U.S. Xpress Enterprises falls -20.6% USX U.S. Xpress Enterprises $10.32 / +0.47 (+4.77%) 06:59 Today BofA U.S. Xpress Enterprises upgraded to Buy from Neutral at BofA 11/23/20 BofA BofA cuts three truckers to Neutral, double downgrades U.S. Xpress 11/23/20 BofA U.S. Xpress Enterprises downgraded to Underperform from Buy at BofA 10/15/20 Stifel U.S. Xpress Enterprises upgraded to Buy amid tight spot market at Stifel USX U.S. Xpress Enterprises $10.32 / +0.47 (+4.77%) 01/28/21 U.S. Xpress Enterprises reports Q4 EPS 15c, consensus 18c 10/22/20 U.S. Xpress reports Q3 EPS 20c, consensus 21c USX U.S. Xpress Enterprises $10.32 / +0.47 (+4.77%) 01/28/21 Fly Intel: After-Hours Movers 10/22/20 Fly Intel: After-Hours Movers 03/15/21 2021 Industrials Virtual Conference

Hot Stocks	Becton Dickinson acquires GSL Solutions, terms undisclosed » 07:02 03/04/21 03/04 07:02 03/04/21 07:02 BDX Becton Dickinson $241.76 / -3.005 (-1.23%) Becton Dickinson… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly BDX Becton Dickinson $241.76 / -3.005 (-1.23%) 02/22/21 Becton Dickinson announces collaboration for at-home rapid test for COVID-19 02/12/21 FDA releases briefing docs ahead of meeting on Becton Dickinson's Lutonix DCB 02/12/21 Becton Dickinson receives EUA from FDA for SARS-CoV-2, Influenza A+B test 02/02/21 Becton Dickinson announces CLEAN3 trial data published BDX Becton Dickinson $241.76 / -3.005 (-1.23%) 02/12/21 Wells Fargo Wells Fargo sees only 'small chance' of positive FDA panel for Becton 02/05/21 Citi Becton Dickinson price target raised to $280 from $273 at Citi 02/04/21 Piper Sandler Becton Dickinson price target raised to $280 from $275 at Piper Sandler 12/15/20 Fly Intel: Top five analyst downgrades BDX Becton Dickinson $241.76 / -3.005 (-1.23%) 02/04/21 Becton Dickinson raises FY21 adj. EPS view to $12.75-$12.85 from $12.40-$12.60 02/04/21 Becton Dickinson reports Q1 adjusted EPS $4.55, consensus $3.11 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open 21 May BDX Becton Dickinson $241.76 / -3.005 (-1.23%) 09/14/20 Becton Dickinson investigating false-positive COVID-19 test results, WSJ reports 09/09/20 Report says U.S. may need 193M coronavirus tests per month, STAT reports BDX Becton Dickinson $241.76 / -3.005 (-1.23%) 02/04/21 Fly Intel: Pre-market Movers
Recommendations	Descartes Systems price target raised to $63 from $59 at Barclays » 07:02 03/04/21 03/04 07:02 03/04/21 07:02 DSGX Descartes Systems / + Barclays analyst Raimo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events DSGX Descartes Systems / + 03/01/21 Descartes Systems acquires QuestaWeb for approximately $36M 11/06/20 Descartes Systems acquires ShipTrack for C$25M upfront 11/04/20 Cover Genius, Descartes partner for ecommerce shipping insurance solutions DSGX Descartes Systems / + 01/04/21 Stephens Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens 11/13/20 Stephens Descartes Systems upgraded to Overweight from Equal Weight at Stephens 09/11/20 Stifel Descartes Systems price target raised to C$78 from C$63 at Stifel 09/11/20 Canaccord Descartes Systems price target raised to C$65 from C$50 at Canaccord DSGX Descartes Systems / + 03/03/21 Descartes Systems reports Q4 EPS 20c, consensus 16c 12/02/20 Descartes Systems reports Q3 EPS 15c, consensus 14c 09/09/20 Descartes Systems reports Q2 EPS 12c, consensus 12c DSGX Descartes Systems / + 12/02/20 Fly Intel: After-Hours Movers 03/10/21 Descartes Systems
Earnings	Bally's reports Q4 adjusted EPS 39c, consensus (8c) » 07:02 03/04/21 03/04 07:02 03/04/21 07:02 BALY Bally's $60.69 / -2.15 (-3.42%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BALY Bally's $60.69 / -2.15 (-3.42%) 02/22/21 Bally's submits proposal to develop casino in Richmond, Virginia 02/18/21 Bally's becomes official sports betting partner of The National Hockey League 02/08/21 Bally's acquires SportCaller for undisclosed amount 01/25/21 Bally's to acquire Monkey Knife Fight in an all-stock transaction BALY Bally's $60.69 / -2.15 (-3.42%) 02/24/21 Truist Bally's price target raised to $80 from $65 at Truist 02/09/21 Stifel Bally's price target raised to $60 from $50 at Stifel 01/14/21 KeyBanc KeyBanc bullish on Bally's, initiates with an Overweight 01/13/21 KeyBanc Bally's initiated with an Overweight at KeyBanc BALY Bally's $60.69 / -2.15 (-3.42%) 11/09/20 Bally's Corporation changes name from Twin River Worldwide Holdings BALY Bally's $60.69 / -2.15 (-3.42%) 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says BALY Bally's $60.69 / -2.15 (-3.42%) 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/19/21 Bet On It: Penn National's lack of promotional spend sets it apart 02/12/21 Bet On It: Texas and Hawaii face opposition to legalized sports betting 02/05/21 Bet On It: Georgia online sports betting bill passes first test 08:00 Today Bally's - BALY
Initiation	American Outdoor Brands initiated with a Buy at B. Riley Securities » 07:02 03/04/21 03/04 07:02 03/04/21 07:02 AOUT American Outdoor Brands $20.17 / -0.58 (-2.80%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AOUT American Outdoor Brands $20.17 / -0.58 (-2.80%) 12/15/20 American Outdoor Brands jumps 7% to $17.00 after beat and raise quarter 12/15/20 American Outdoor Brands reports Q2 e-commerce channel sales up 213.4% 12/15/20 American Outdoor Brands reports Q2 gross margin 46.9%, up 690 bps 09/23/20 American Outdoor Brands up over 2% after disclosing insider purchase by CEO, CFO AOUT American Outdoor Brands $20.17 / -0.58 (-2.80%) 01/22/21 Fly Intel: Top five analyst upgrades 01/22/21 Wedbush American Outdoor Brands upgraded to Outperform from Neutral at Wedbush 01/22/21 Wedbush American Outdoor Brands upgraded to Outperform from Neutral at Wedbush 12/16/20 Lake Street Lake Street ups American Outdoor Brands price target to $24 after Q2 report AOUT American Outdoor Brands $20.17 / -0.58 (-2.80%) 12/15/20 American Outdoor Brands raises FY21 adj. EPS view to $1.49-$1.67 from 78c-89c 12/15/20 American Outdoor Brands reports Q2 adjusted EPS 77c, consensus 25c AOUT American Outdoor Brands $20.17 / -0.58 (-2.80%) 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/16/20 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: After-Hours Movers 03/17/21 American Outdoor Brands - AOUT AOUT American Outdoor Brands $20.17 / -0.58 (-2.80%) 12/15/20 American Outdoor Brands options imply 17.3% move in share price post-earnings 09/10/20 Five new option listings and one option delisting on September 10th
Earnings	Purple Innovation reports Q4 adjusted EPS 7c, consensus 11c » 07:02 03/04/21 03/04 07:02 03/04/21 07:02 PRPL Purple Innovation $36.25 / -1.64 (-4.33%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options PRPL Purple Innovation $36.25 / -1.64 (-4.33%) 10/19/20 Purple Innovation signs exclusive partnership with Sleep Country Canada PRPL Purple Innovation $36.25 / -1.64 (-4.33%) 01/12/21 B. Riley Securities Purple Innovation price target raised to $41 from $20 at B. Riley Securities 01/12/21 Wedbush Purple Innovation price target raised to $38 from $32 at Wedbush 12/16/20 Truist Purple Innovation initiated with a Buy at Truist 12/16/20 Evercore ISI Purple Innovation initiated with an Outperform at Evercore ISI PRPL Purple Innovation $36.25 / -1.64 (-4.33%) 11/11/20 Notable companies reporting after market close 11/10/20 Purple Innovation reports Q3 adjusted EPS 27c, consensus 24c 10 Sep 15 May PRPL Purple Innovation $36.25 / -1.64 (-4.33%) 11/10/20 Fly Intel: After-Hours Movers 09/10/20 Fly Intel: Pre-market Movers 09/09/20 Fly Intel: After-Hours Movers 08:30 Today Purple Innovation - PRPL PRPL Purple Innovation $36.25 / -1.64 (-4.33%) 12/24/20 Purple Innovation call volume above normal and directionally bullish 12/07/20 Unusual call flow in option market yesterday 12/04/20 Unusual call volume in Purple Innovation as shares traded up 4% 12/01/20 Largest borrow rate increases among liquid names

Recommendations	American Eagle price target raised to $37 from $31 at UBS » 07:01 03/04/21 03/04 07:01 03/04/21 07:01 AEO American Eagle / + UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AEO American Eagle / + 03/03/21 American Eagle CFO says Q1 revenue, op. income to exceed Q1 of 2019 and 2020 03/03/21 American Eagle reinstates quarterly dividend at 13.75 per share 03/03/21 American Eagle sees FY21 CapEx $250M-$275M 01/21/21 American Eagle targeting 600-700 AE stores in U.S. and Canada AEO American Eagle / + 06:49 Today Citi American Eagle price target raised to $32 from $29 at Citi 02/24/21 Cowen American Eagle upgraded to Outperform from Market Perform at Cowen 02/24/21 Cowen American Eagle upgraded to Outperform from Market Perform at Cowen 01/25/21 RBC Capital American Eagle upgraded to Outperform from Sector Perform at RBC Capital AEO American Eagle / + 03/03/21 American Eagle Outfitters reports Q4 adjusted EPS 39c, consensus 36c 03/03/21 Notable companies reporting after market close 01/21/21 American Eagle sees Q4 revenue down low single digits, consensus $1.31B 11/24/20 American Eagle reports Q3 EPS 35c, consensus 34c AEO American Eagle / + 11/05/20 American Eagle partners with Disney for holiday collaboration, WWD reports AEO American Eagle / + 03/03/21 Fly Intel: After-Hours Movers 02/24/21 Square, Workhorse downgrades among today's top calls on Wall Street 11/24/20 Fly Intel: After-Hours Movers 10/14/20 Microsoft resumption, Nio upgrade among top calls on Wall Street AEO American Eagle / + 12/29/20 American Eagle call volume above normal and directionally bullish 11/24/20 American Eagle options imply 10.4% move in share price post-earnings 10/29/20 American Eagle put volume heavy and directionally bearish 10/19/20 American Eagle put volume heavy and directionally bearish
Upgrade	CGI Inc. upgraded to Buy from Hold at Edward Jones » 07:01 03/04/21 03/04 07:01 03/04/21 07:01 GIB CGI Inc. $76.26 / -1.97 (-2.52%) Edward Jones analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings GIB CGI Inc. $76.26 / -1.97 (-2.52%) 02/26/21 CGI Inc. announces IT delivery center in Knoxville, Tennessee 02/23/21 CGI awarded contract by Virginia Department of General Services 02/22/21 CGI Inc. awarded ESA contract to develop wildfire mapping service 02/02/21 CAE expands strategic partnership with CGI Inc. GIB CGI Inc. $76.26 / -1.97 (-2.52%) 02/01/21 Barclays CGI Inc. price target raised to $89 from $80 at Barclays 01/28/21 Canaccord CGI Inc. price target raised to C$112 from C$105 at Canaccord 01/28/21 BMO Capital CGI Inc. price target raised to C$115 from C$107 at BMO Capital 01/28/21 RBC Capital CGI Inc. price target raised to C$115 from C$110 at RBC Capital GIB CGI Inc. $76.26 / -1.97 (-2.52%) 01/27/21 CGI Inc. reports Q1 ex-items EPS C$1.33 vs. C$1.23 last year 11/11/20 CGI Inc. reports Q4 EPS C$1.22, vs. C$1.21 last year
Downgrade	Orica downgraded to Neutral from Buy at Citi » 07:01 03/04/21 03/04 07:01 03/04/21 07:01 OCLDY Orica $0.00 / + (+0.00%) Citi analyst Sam Teeger… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research OCLDY Orica $0.00 / + (+0.00%) 11/20/20 Jefferies Orica downgraded to Hold on tough trading backdrop at Jefferies 11/20/20 Jefferies Orica downgraded to Hold from Buy at Jefferies 04/22/20 JPMorgan Orica upgraded to Neutral from Underweight at JPMorgan 03/28/20 Goldman Sachs Orica upgraded to Buy from Sell at Goldman Sachs
General news	FX Update: The dollar has traded firmer » 07:00 03/04/21 03/04 07:00 03/04/21 07:00 FX Update: The dollar has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Mallinckrodt announces publication of CONFIRM study results » 06:59 03/04/21 03/04 06:59 03/04/21 06:59 MNK Mallinckrodt $0.00 / + (+0.00%) Mallinckrodt announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Options MNK Mallinckrodt $0.00 / + (+0.00%) 02/26/21 Silence, Mallinckrodt initiate work on third target in collaboration 02/22/21 DBV Technologies appoints Michele Robertson as chief legal officer 02/12/21 Mallinckrodt announces FDA to defer action on StrataGraft BLA 11/16/20 Mallinckrodt announces findings from database review of HRS, AKI patients MNK Mallinckrodt $0.00 / + (+0.00%) 08/06/20 Citi Mallinckrodt price target lowered to $1 from $2 at Citi 08/05/20 BMO Capital Mallinckrodt price target lowered to $2 from $4 at BMO Capital 08/04/20 Piper Sandler Mallinckrodt downgraded to Underweight from Neutral at Piper Sandler 07/14/20 BMO Capital Briefing docs suggest AdComm 'challenges' for Mallinckrodt, says BMO Capital MNK Mallinckrodt $0.00 / + (+0.00%) 10/21/20 Purdue Pharma to plead guilty in $8B-plus deal, AP reports 09/25/20 Mallinckrodt nearing bankruptcy filing, negotiating with key creditors, WSJ says 09/25/20 Mallinckrodt nearing bankruptcy filing over opioid suits, WSJ says MNK Mallinckrodt $0.00 / + (+0.00%) 10/13/20 Three new option listings and three option delistings on October 13th 10/08/20 Largest borrow rate increases among liquid names

Recommendations	Wendy's should look outside organic growth plans, says Stifel » 06:59 03/04/21 03/04 06:59 03/04/21 06:59 WEN Wendy's / + Stifel analyst Chris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's / + 03/03/21 Wendy's CEO: Loyalty program driving frequency, should continue to pay dividends 03/03/21 Wendy's says Q1 sales 'off to a strong start' 03/03/21 Wendy's sees FY21 cash flows from operations: $310M-$330M 03/03/21 Wendy's reports Q4 global same-restaurant sales growth 4.7% WEN Wendy's / + 03/03/21 Wells Fargo Wells Fargo lowers Wendy's target to $22 as current performance misses mark 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank WEN Wendy's / + 03/03/21 Wendy's sees FY21 adjusted EPS 67c-69c, consensus 72c 03/03/21 Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's / + 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 03/16/21 Wendy's
Upgrade	Werner upgraded to Buy from Neutral at BofA » 06:59 03/04/21 03/04 06:59 03/04/21 06:59 WERN Werner / + BofA analyst Ken Hoexter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly WERN Werner / + 02/25/21 Werner increases quarterly cash dividend 11% to 10c per share 01/27/21 Werner announces sale of WGL unit to Scan Global Logistics Group 01/20/21 Werner announces equity investment in TuSimple 09/16/20 Werner, Platform Science announce technology partnership WERN Werner / + 01/26/21 Susquehanna Werner downgraded to Neutral from Positive at Susquehanna 01/26/21 Susquehanna Werner downgraded to Neutral from Positive at Susquehanna 01/19/21 Credit Suisse Werner upgraded to Neutral from Underperform at Credit Suisse 12/14/20 Wells Fargo Werner downgraded to Underweight from Equal Weight at Wells Fargo WERN Werner / + 02/04/21 Werner reports Q4 adjusted EPS 89c, consensus 78c 10/28/20 Werner reports Q3 EPS 69c, consensus 66c 04 Jun WERN Werner / + 10/28/20 Fly Intel: After-Hours Movers
Upgrade	Schneider National upgraded to Buy from Neutral at BofA » 06:58 03/04/21 03/04 06:58 03/04/21 06:58 SNDR Schneider National / + BofA analyst Ken Hoexter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SNDR Schneider National / + 01/20/21 Schneider National takes investment stake in TuSimple 12/16/20 Schneider National to increase driver pay in 2021 10/29/20 Schneider National declares special dividend of $2.00 per share SNDR Schneider National / + 02/01/21 KeyBanc Schneider National upgraded to Overweight from Sector Weight at KeyBanc 02/01/21 KeyBanc Schneider National upgraded to Overweight from Sector Weight at KeyBanc 01/26/21 Susquehanna Schneider National downgraded to Neutral from Positive at Susquehanna 01/26/21 Susquehanna Schneider National downgraded to Neutral from Positive at Susquehanna SNDR Schneider National / + 02/03/21 Schneider National sees FY21 adjusted EPS $1.45-$1.60, consensus $1.55 02/03/21 Schneider National reports Q4 adjusted EPS 44c, consensus 39c 10/29/20 Schneider National raises FY20 adj. EPS view to $1.18-$1.22 from $1.10-$1.25 10/29/20 Schneider National reports Q3 adj. EPS 31c, consensus 31c
Upgrade	Svenska Handelsbanken upgraded to Neutral from Sell at Citi » 06:58 03/04/21 03/04 06:58 03/04/21 06:58 SVNLY Svenska Handelsbanken $0.00 / + (+0.00%) Citi analyst Maria… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SVNLY Svenska Handelsbanken $0.00 / + (+0.00%) 02/05/21 Berenberg Svenska Handelsbanken price target raised to SEK 87 from SEK 83 at Berenberg 02/04/21 Deutsche Bank Svenska Handelsbanken price target raised to SEK 113 at Deutsche Bank 01/21/21 Barclays Svenska Handelsbanken price target raised to SEK 105 from SEK 102 at Barclays 01/14/21 SEB Equities Svenska Handelsbanken upgraded to Hold from Sell at SEB Equities
Upgrade	Knight-Swift upgraded to Buy from Neutral at BofA » 06:58 03/04/21 03/04 06:58 03/04/21 06:58 KNX Knight-Swift $45.27 / +0.76 (+1.71%) BofA analyst Ken Hoexter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options KNX Knight-Swift $45.27 / +0.76 (+1.71%) 02/01/21 Knight-Swift acquires majority stake in mobile driver workflow firm Eleos 09/29/20 Knight-Swift aims to reduce carbon emissions by 50% by 2035 KNX Knight-Swift $45.27 / +0.76 (+1.71%) 01/14/21 Citi Knight-Swift price target raised to $48 from $46 at Citi 01/07/21 Wolfe Research Knight-Swift downgraded to Peer Perform from Outperform at Wolfe Research 12/04/20 Evercore starts trucking coverage with preference for Old Dominion, Saia 12/04/20 Evercore ISI Knight-Swift initiated with an In Line at Evercore ISI KNX Knight-Swift $45.27 / +0.76 (+1.71%) 01/27/21 Knight-Swift reports Q4 adjusted EPS 94c, consensus 91c 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/21/20 Knight-Swift sees FY21 adj. EPS $3.20-$3.40, consensus $2.83 KNX Knight-Swift $45.27 / +0.76 (+1.71%) 10/05/20 Knight Transportation call buyer realizes 11% same-day gains

Hot Stocks	Eli Lilly announces results from SURPASS-2 clinical trial » 06:58 03/04/21 03/04 06:58 03/04/21 06:58 LLY Eli Lilly $201.93 / -2.24 (-1.10%) Tirzepatide led to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY Eli Lilly $201.93 / -2.24 (-1.10%) 03/03/21 Eli Lilly, Incyte announce BRAVE-AA2 study met primary endpoint 02/26/21 Eli Lilly awarded $210M Army contract for 100,000 doses of antibody therapeutic 02/26/21 Eli Lilly awarded $2.52B Army contract for LY-CoV555, LY-CoV016 02/26/21 Eli Lilly: Additional doses of neutralizing antibody therapy purchased by U.S. LLY Eli Lilly $201.93 / -2.24 (-1.10%) 03/02/21 JPMorgan Eli Lilly risk/reward favorable into Alzheimer's data, says JPMorgan 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 02/12/21 Cowen Eli Lilly price target raised to $235 from $195 at Cowen LLY Eli Lilly $201.93 / -2.24 (-1.10%) 01/29/21 Eli Lilly backs FY21 EPS view $7.75-$8.40, consensus $8.20 01/29/21 Eli Lilly reports Q4 EPS $2.75, consensus $2.35 01/28/21 Notable companies reporting before tomorrow's open 01/28/21 Notable companies reporting before tomorrow's open LLY Eli Lilly $201.93 / -2.24 (-1.10%) 02/10/21 Eli Lilly won't try to claw back past pay from former CFO Smiley, WSJ reports 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says LLY Eli Lilly $201.93 / -2.24 (-1.10%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday 01/29/21 Fly Intel: Wall Street's top stories at midday 03/05/21 Healthcare 03/02/21 41st Annual Healthcare Virtual Conference 03/10/21 Global Healthcare Virtual Conference 2021 03/15/21 Eli Lilly - LLY 04/27/21 Eli Lilly - LLY LLY Eli Lilly $201.93 / -2.24 (-1.10%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th
Upgrade	J.B. Hunt upgraded to Buy from Neutral at BofA » 06:58 03/04/21 03/04 06:58 03/04/21 06:58 JBHT J.B. Hunt $152.57 / +1.7 (+1.13%) BofA analyst Ken Hoexter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options JBHT J.B. Hunt $152.57 / +1.7 (+1.13%) 03/01/21 J.B. Hunt Chairman James Thompson sold over $750K in company shares 01/27/21 Navistar partners with General Motors, J.B. Hunt for hydrogen truck ecosystem 01/19/21 J.B. Hunt jumps 3% to $153.00 after Q4 earnings beat 01/19/21 J.B. Hunt says Q4 revenue growth driven by ICS and Truck segments JBHT J.B. Hunt $152.57 / +1.7 (+1.13%) 01/26/21 Susquehanna J.B. Hunt downgraded to Neutral from Positive at Susquehanna 01/26/21 Susquehanna J.B. Hunt downgraded to Neutral from Positive at Susquehanna 01/21/21 Deutsche Bank J.B. Hunt price target raised to $146 from $139 at Deutsche Bank 01/20/21 JPMorgan J.B. Hunt shares will 'lag the group,' says JPMorgan JBHT J.B. Hunt $152.57 / +1.7 (+1.13%) 01/19/21 J.B. Hunt reports Q4 EPS $1.44, consensus $1.30 01/19/21 Notable companies reporting after market close 10/16/20 J.B. Hunt reports Q3 EPS $1.18, consensus $1.27 10/15/20 Notable companies reporting before tomorrow's open JBHT J.B. Hunt $152.57 / +1.7 (+1.13%) 01/30/21 Charged: Tesla reports first profit miss in over a year 01/19/21 Fly Intel: After-Hours Movers 10/16/20 Fly Intel: Pre-market Movers JBHT J.B. Hunt $152.57 / +1.7 (+1.13%) 01/19/21 J B Hunt Transport Services options imply 5.8% move in share price post-earnings 10/01/20 Early notable gainers among liquid option names on October 1st
Recommendations	Agco price target raised to $200 from $155 at BMO Capital » 06:57 03/04/21 03/04 06:57 03/04/21 06:57 AGCO Agco $126.04 / -3.1 (-2.40%) BMO Capital analyst Joel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AGCO Agco $126.04 / -3.1 (-2.40%) 03/03/21 AGCO announces farmer-first strategy 02/19/21 Agco says TAFE letter to board makes 'a number of misleading statements' 10/13/20 Agco chief communication officer Ulrich Stockheim to depart company AGCO Agco $126.04 / -3.1 (-2.40%) 06:52 Today Deutsche Bank Agco price target raised to $145 from $141 at Deutsche Bank 02/08/21 BMO Capital Agco price target raised to $155 from $130 at BMO Capital 01/20/21 Vertical Research Agco initiated with a Hold at Vertical Research 01/15/21 Jefferies Agco price target raised to $135 from $105 at Jefferies AGCO Agco $126.04 / -3.1 (-2.40%) 02/04/21 Agco sees FY21 EPS $7.00-$7.25, consensus $6.28 02/04/21 Agco reports Q4 EPS $1.54, consensus $1.11 11/03/20 Agco raises FY20 adj. EPS view to approximately $5.00 from $3.50-$3.75 11/03/20 Agco reports Q3 EPS $2.09, consensus 98c
Hot Stocks	Burlington Stores reports Q4 gross margin 42.5% vs. 42.1% last year » 06:55 03/04/21 03/04 06:55 03/04/21 06:55 BURL Burlington Stores $252.46 / -6.51 (-2.51%) Merchandise margins… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BURL Burlington Stores $252.46 / -6.51 (-2.51%) 06:47 Today Burlington Stores sees FY21 CapEx $470M 11/24/20 Burlington Stores lowers FY20 CapEx view to $245M from $400M BURL Burlington Stores $252.46 / -6.51 (-2.51%) 02/16/21 JPMorgan Burlington Stores price target raised to $259 from $254 at JPMorgan 01/27/21 Citi Burlington Stores downgraded to Neutral from Buy at Citi 01/22/21 Loop Capital Burlington Stores price target raised to $290 from $255 at Loop Capital 01/21/21 Deutsche Bank Burlington Stores price target raised to $279 from $246 at Deutsche Bank BURL Burlington Stores $252.46 / -6.51 (-2.51%) 06:46 Today Burlington Stores reports Q4 adjusted EPS $2.44, consensus $2.12 03/03/21 Notable companies reporting before tomorrow's open 03/03/21 Notable companies reporting before tomorrow's open 11/24/20 Burlington Stores reports Q3 non-GAAP EPS 29c, consensus 16c BURL Burlington Stores $252.46 / -6.51 (-2.51%) 11/24/20 Fly Intel: Pre-market Movers 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 10/28/20 AMD, Lululemon upgrades among today's top calls on Wall Street 10/27/20 Foot Locker, DocuSign initiations among today's top calls on Wall Street 08:30 Today Burlington Stores - BURL BURL Burlington Stores $252.46 / -6.51 (-2.51%) 10/09/20 Unusual call flow in option market yesterday 10/08/20 Call spread in Burlington Stores rolls two week 300% winner
Syndicate	TherapeuticsMD files $100M mixed securities shelf 06:55 03/04/21 03/04 06:55 03/04/21 06:55 TXMD TherapeuticsMD $1.46 / + (+0.00%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options TXMD TherapeuticsMD $1.46 / + (+0.00%) 11/09/20 TherapeuticsMD begins process to divest vitaCare Prescription Services 09/21/20 TherapeuticsMD, Knight announces Health Canada approval of BIJUVA 09/09/20 TherapeuticsMD announces patent updates for Annovera TXMD TherapeuticsMD $1.46 / + (+0.00%) 01/28/21 H.C. Wainwright TherapeuticsMD price target lowered to $4 from $5 at H.C. Wainwright 08/07/20 Jefferies Jefferies downgrades 'show-me story' TherapeuticsMD to Underperform 08/07/20 Jefferies TherapeuticsMD downgraded to Underperform from Hold at Jefferies 05/19/20 Fly Intel: Top five analyst downgrades TXMD TherapeuticsMD $1.46 / + (+0.00%) 03/02/21 TherapeuticsMD reports Q4 EPS (15c), consensus (10c) 11/09/20 TherapeuticsMD reports Q3 EPS (12c) with items, consensus (14c) 09/25/20 TherapeuticsMD says on track to meet or exceed Q3 revenue consensus of $15.1M 11 Feb 10 Nov TXMD TherapeuticsMD $1.46 / + (+0.00%) 02/10/21 Fly Intel: After-Hours Movers TXMD TherapeuticsMD $1.46 / + (+0.00%) 03/02/21 Unusually active option classes on open March 2nd 10/27/20 Largest borrow rate increases among liquid names 10/06/20 Largest borrow rate increases among liquid names 09/16/20 Largest borrow rate increases among liquid names

Events

Earnings calls, analyst events, roadshows and more

Today at 07:30

Challenger Job-Cut Report Level: February 2021 Government Event
HCM
Today at 08:00

Hutchison China MediTech - HCM Conference Calls
BALY
Today at 08:00

Bally's - BALY Conference Calls
ATC
Today at 08:00

Atotech - ATC Conference Calls
WVE
Today at 08:00

Wave Life Sciences - WVE Conference Calls
FULC
Today at 08:00

Fulcrum Therapeutics - FULC Conference Calls
Today at 08:00

Consumer Data Analytics Industry Meetings
Today at 08:30

Initial Jobless Claims Change: Week 2/27/2021 Government Event
Today at 08:30

Jobless Claims: 4-Week Moving Average: Week 2/27/2021 Government Event
Today at 08:30

Productivity & Costs: Non-farm Poductivity Annual Rate: Q4(r):2020 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50-47.00 3.9M Shares AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James $34.00-35.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR $11.50-11.75 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

Apple to accelerate production shift outside China, Nikkei Asia says

TODAY'S FREE FLY STORIES

Get Full Fly Access